Goldman Jonathan

Track

Insider profile

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -23% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Goldman Jonathan's trades of Avalo Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-06-02
PrS Proposed sale
96,429
161.55
US$2,653,656 		96,429 161.55 US$2,653,656
2025-11-17 2025-11-14
S Sale
41,194 +24.8%
199.11
US$3,270,747 		41,194 +24.8% 199.11 US$3,270,747
2025-11-17 2025-11-14
S Sale
6,799 -4.7%
325.48
US$2,707,559 		6,799 -4.7% 325.48 US$2,707,559